Center-Authored Papers

Filters: Author is de Koning, Harry J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Gulati R, Wever EM, Tsodikov A, Penson DF, Inoue LYT, Katcher J, Lee S-Y, Heijnsdijk EAM, Draisma G, de Koning HJ et al..  2011.  What if i don't treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(5):740-50. Abstract
2012
Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F et al..  2012.  Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000.. Journal of the National Cancer Institute. 104(7):541-8. Abstract
Etzioni R, Gulati R, Tsodikov A, Wever EM, Penson DF, Heijnsdijk EAM, Katcher J, Draisma G, Feuer EJ, de Koning HJ et al..  2012.  The prostate cancer conundrum revisited : Treatment changes and prostate cancer mortality declines.. Cancer. Abstract
Gulati R, Tsodikov A, Wever EM, Mariotto AB, Heijnsdijk EAM, Katcher J, de Koning HJ, Etzioni R.  2012.  The impact of PLCO control arm contamination on perceived PSA screening efficacy.. Cancer causes & control : CCC. 23(6):827-35. Abstract
2013
de Koning HJ, Meza R, Plevritis SK, Ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J et al..  2013.  Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force.. Annals of internal medicine. Abstract
2014
McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi MC, Erdogan A, Ten Haaf K, Hazelton W, Holford TR, Jeon J et al..  2014.  Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the national lung screening trial using comparative modeling.. PloS one. 9(6):e99978. Abstract
Meza R, Ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V et al..  2014.  Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.. Cancer. Abstract
Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EAM, Pabiniak C, van Ballegooijen M et al..  2014.  Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.. Annals of internal medicine. 161(2):104-12. Abstract
Aged
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
August 2014
Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EAM, Pabiniak C, van Ballegooijen M et al..  2014.  Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.. Annals of internal medicine. 161(2):104-12. Abstract
Biopsy
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
Breast
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
Breast Neoplasms
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
Computer Simulation
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
Cost-Benefit Analysis
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
Early Detection of Cancer
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
False Positive Reactions
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
Female
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
Humans
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
January 2014
de Koning HJ, Meza R, Plevritis SK, Ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J et al..  2013.  Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force.. Annals of internal medicine. Abstract
July 2014
McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi MC, Erdogan A, Ten Haaf K, Hazelton W, Holford TR, Jeon J et al..  2014.  Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the national lung screening trial using comparative modeling.. PloS one. 9(6):e99978. Abstract
June 2012
Etzioni R, Gulati R, Tsodikov A, Wever EM, Penson DF, Heijnsdijk EAM, Katcher J, Draisma G, Feuer EJ, de Koning HJ et al..  2012.  The prostate cancer conundrum revisited : Treatment changes and prostate cancer mortality declines.. Cancer. Abstract
Mammography
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
March 2012
Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F et al..  2012.  Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000.. Journal of the National Cancer Institute. 104(7):541-8. Abstract
March 2014
Meza R, Ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V et al..  2014.  Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.. Cancer. Abstract